Recently, acquired resistance to EGFR specific inhibitors in NSCLC mutant cell lines has been hypothesized to relate to the activation of the FGFR1-FGF2 autocrine loop [117]. This evidence concerns the gene FGFR1 and non-small cell lung carcinoma.